Skip to main content

Table 2 Summary of tumor response

From: Preliminary evidence for endoscopic surgery combined with postoperative anti-PD-1 immunotherapy in advanced recurrent nasopharyngeal carcinoma

Variable

ENPG alone group (n = 20)

Consolidation immunotherapy group (n = 10)

p-value

Complete response, n (%)

3 (15.0)

1 (10.0)

0.704

Partial response, n (%)

4 (20.0)

5 (50.0)

0.091

Satable disaese, n (%)

1 (5.0)

2 (20.0)

0.197

Progressive disease, n (%)

12 (60.0)

2 (20.0)

0.038

Objective response % (95% CI)

35.0 (14.1–55.9)

60.0 (29.6–90.4)

0.193

Disease control rate % (95% CI)

40.0 (18.5–61.5)

80.0 (55.2–104.8)

0.038

  1. Abbreviation: ENPG endoscopic nasopharyngectomy